2006
DOI: 10.1016/j.biomaterials.2005.09.020
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of folate-chitosan-DNA nanoparticles for gene therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
213
0
1

Year Published

2006
2006
2020
2020

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 368 publications
(218 citation statements)
references
References 24 publications
4
213
0
1
Order By: Relevance
“…Preparation of chitosan-DNA nanoparticles (CS/pDNA) [28] Described the method of CS/DNA formation as follow: Two types of CS, each of a different molecular weight, were dissolved separately in 25 mM acetic acid, which was then adjusted to pH 5.5 at a final concentration of 1% (stock solution). The stock solution was then diluted with distilled water to form different concentrations of CS solution (0.01, 0.02, 0.04 and 0.08%).…”
Section: 62mentioning
confidence: 99%
“…Preparation of chitosan-DNA nanoparticles (CS/pDNA) [28] Described the method of CS/DNA formation as follow: Two types of CS, each of a different molecular weight, were dissolved separately in 25 mM acetic acid, which was then adjusted to pH 5.5 at a final concentration of 1% (stock solution). The stock solution was then diluted with distilled water to form different concentrations of CS solution (0.01, 0.02, 0.04 and 0.08%).…”
Section: 62mentioning
confidence: 99%
“…Folic acid could be easily absorbed by cells, promoting the targeting and internalization of drug. Mansouri et al 58 used folic acid to modify chitosan for improving gene transfection efficiency. They studied systematically the characteristics of folic acid for gene treatment, finding that folic acid-modified chitosan nanoparticles had low cell toxicity and could condense DNA effectively with ideal size and zeta potential.…”
mentioning
confidence: 99%
“…Many research studies have been conducted for enhancement of transfection efficiency, such as pHsensitive modification , Jones, et al, 2003, Kim, et al, 2003, Wong, et al, 2006, temperature-sensitive modification , Dang, et al, 2006, Sun, et al, 2005, specific target ligand modification (Hashimoto, et al, 2006, Mansouri, et al, 2006, Wu & Wu, 1998 and so on. Among the chemical modifications of chitosan, PEI grafted chitosan showed some benefit due to high transfection efficiency.…”
Section: Cyclodextrinmentioning
confidence: 99%